About Signalife, Inc.
Signalife, Inc. is a life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting. Signalife, Inc. is the recipient of the Frost & Sullivan Technological Innovation Award for 2006.
Signalife, Inc. is traded on the American Stock Exchange under the symbol SGN. More information is located at http://www.signalife.com.
Caution Regarding Forward-Looking Statements
In this news release we make a number of statements, referred to as
"forward-looking statements", which are intended to convey our expectations
or predictions regarding the occurrence of possible future events or the
existence of trends and factors that may impact our future plans and
operating results. Any statements in this news release that are not
statements of historical fact maybe considered to be forward-looking
statements. These forward-looking statements are derived, in part, from
various assumptions and analyses we have made in the context of our current
business plan and information currently available to us and in light of our
experience and perceptions of historical trends, current conditions and
expected future developments and other factors we believe to be appropriate
in the circumstances. You can generally identify forward-looking statements
through words and phrases such as "seek", "anticipate", "believe",
"estimate", "expect", "intend", "plan", "budget", "project", "may be", "may
continue", "may likely result", and similar expressions. Each
forward-looking statement should be read in context with, and with an
understanding of, the various other disclosures concerning our company and
our business made in this news release as w
|SOURCE Signalife, Inc.|
Copyright©2008 PR Newswire.
All rights reserved